Can a chronic care model collaborative reduce heart disease risk in patients with diabetes?

Journal of General Internal Medicine

Volumn 22, Issue 2, 2007, Pages 215-222

  Vargas, Roberto B ^a,b   Mangione, Carol M ^a,b   Asch, Steven ^a,b   Keesey, Joan ^b   Rosen, Mayde ^b   Schonlau, Matthias ^b   Keeler, Emmett B ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b RAND CORPORATION   (United States)

Author keywords

Cardiovascular disease; Chronic care; Collaborative; Diabetes; Intervention

Indexed keywords

HEMOGLOBIN;

ADULT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEALTH CARE ORGANIZATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTERVENTION STUDY; LIPID BLOOD LEVEL; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; TREATMENT OUTCOME; AGED; BIOLOGICAL MODEL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; COOPERATION; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR;

AGED; CARDIOVASCULAR DISEASES; COOPERATIVE BEHAVIOR; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LONG-TERM CARE; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; RISK FACTORS;

EID: 34250316987     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-006-0072-5     Document Type: Article

References (45)

1. Sowers JR. Diabetes mellitus and cardiovascular disease in women. Arch Intern Med. 1998;158:617-21.
2. Tedesco JV, Wright RS, Williams BA, et al. Effect of diabetes on the mortality risk of cardiogenic shock in a community-based population. Mayo Clin Proc. 2003;78(5):561-6.
3. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339(4):229-34.
4. Winer N, Sowers JR. Cardiovascular risk factors in diabetic patients with hypertension. Curr Diab Rep. 2002;2(3):263-6.
5. Almdal T, Scharling H, Jensen J, Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med. 2004;164(13):1422-6.
6. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998;351(9118):1755-62.
7. American Diabetes Association: clinical practice recommendations 2000. Diabetes Care. 2000;23 Suppl 1:S1-116.
8. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157(21):2413-46.
9. United Kingdom Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837-53.
10. Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care. 1997;20(4):614-20.
11. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348(5):383-93.
12. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-86.
13. Snow V, Aronson M, Hornbake ER, Mottur-Pilson C, Weiss KB; The Clinical Efficacy Subcommittee of the American College of Physicians. Lipid control in the management of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2004;140(8):644-9.
14. California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc. 2003;51(5s):S265-80.
15. Vinik AI, Vinik E. Prevention of the complications of diabetes. Am J Manag Care. 2003;9(3 Suppl):S63-80; quiz S81-4.
16. United Kingdom Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317(7160):703-13.
17. Garfield SA MS, Chin MH, Venkat Narayan KM, et al. Considerations for diabetes translational research in real-world settings. Diabetes Care 2003;26(9):2670-4.
18. Renders CM, Valk GD, Griffin SJ, Wagner EH, Eijk Van JT, Assendelft WJ. Interventions to improve the management of diabetes in primary care, outpatient, and community settings: a systematic review. Diabetes Care. 2001;24(10):1821-33.
19. Berwick DM. Disseminating innovations in health care. JAMA. 2003;289(15):1969-75.
20. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, Part 2. JAMA. 2002;288(15):1909-14.
21. Wagner EH, Glasgow RE, Davis C, et al. Quality improvement in chronic illness care: a collaborative approach. Jt Comm J Qual Improv. 2001;27:63-80.
22. Chin MH, Cook S, Drum ML, et al. Improving diabetes care in midwest community health centers with the health disparities collaborative. Diabetes Care. 2004;27(1):2-8.
23. Mangione-Smith R, Schonlau M, Chan KS, et al. Measuring the effectiveness of a collaborative for quality improvement in pediatric asthma care: does implementing the chronic care model improve processes and outcomes of care? Ambul Pediatr. 2005;5(2):75-82.
24. Asch SM BD, Keesey JW, Broder M, et al. Does the collaborative model improve care for chronic heart failure? Med Care. 2005;43(7):667-75.
25. Piatt GA, Orchard TJ, Emerson S, et al. Translating the chronic care model into the community: results from a randomized controlled trial of a multifaceted diabetes care intervention. Diabetes Care. 2006;29(4):811-7.
26. Institute for Healthcare Improvement. The breakthrough series: IHI's collaborative model for achieving breakthrough improvement, http://www.ihi.org/ IHI/Products/WhitePapers/ TheBreakthroughSeriesIHIsCollaborativeModelforAchieving%20Breakthrough Improvement, 2005. Accessed 10.12.06
27. Landon BE, Wilson IB, McInnes K, et al. Effects of a quality improvement collaborative on the outcome of care of patients with HIV infection: the EQHIV study. Ann Intern Med. 2004;140(11):887-96.
28. Horbar JD, Rogowski J, Plsek PE, et al. Collaborative quality improvement for neonatal intensive care. Pediatrics. 2001;107(1):14-22.
29. Solberg L, Kottke T, Brekke M, et al. Failure of a continuous quality improvement intervention to increase the delivery of preventive services a randomized trial. Eff Clin Pract. 2000;3(3):153-5.
30. Pearson ML WS, Schaefer J, Bonomi AE, et al. Assessing the implementation of the chronic care model in quality improvement collaboratives. Health Serv Res. 2005;40(4):978-96.
31. Cretin S, Shortell SM, Keeler EB. An evaluation of collaborative interventions to improve chronic illness care. Framework and study design. Eval Rev. 2004;28(1):28-51.
32. Stevens RJ, Kothari V, Adler AI, Stratton IM. The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci (Lond). 2001;101(6):671-9.
33. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83.
34. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206-52.
35. Vijan S, Hayward RA. Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care. Ann Intern Med. 2003;138(7):593-602.
36. Collins R, Armitage J, Parish S, Sleigh P, Peto R; Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet. 2003;361(9374):2005-16.
37. Khaw K-T, Wareham N, Bingham S, Luben R, Welch A, Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med. 2004;141(6):413-20.
38. Sung NS, Crowley WF, Jr., Genel M, et al. Central challenges facing the national clinical research enterprise. JAMA. 2003;289:1278-87.
39. Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003;290:1624-32.
40. National Committee for Quality Assurance. The State of Health Care Quality. 2003. 2000 L Street, NW Suite 500, Washington D.C. 20036. Page 50.
41. Bowman MA, Konen JC. Quality of outpatient care: diabetes. JAMA. 1995;274:1584; author reply 1585.
42. Clemenson N. Quality of outpatient care: diabetes. JAMA. 1995;274(20):1584; author reply 1585.
43. Frijling BD, Lobo CM, Keus IM, et al. Perceptions of cardiovascular risk among patients with hypertension or diabetes. Patient Educ Couns. 2004;52(1):47-53.
44. Nelson K, Garcia RE, Brown J, et al. Do patient consent procedures affect participation rates in health services research? Med Care. 2002;40:283-8.
45. U.S. Department of Health and Human Services Center for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States 2003. Atlanta, GA: 2004.